Crossmark

Managing Cluster Headache in Patients with Medical, Psychiatric, and Surgical Comorbidities

Published Online: 2024-07-17

Published Print: 2024-09

Authors

Burish, Mark J.

Guirguis, Alexander B.

Schindler, Emmanuelle A. D.
License Information

Text and Data Mining valid from 2024-07-17

Version of Record valid from 2024-07-17
More Information

Article History

Accepted: 6 July 2024

First Online: 17 July 2024

Declarations

:

: The authors declare no competing interests.

: MJB currently receives research funding from Will Erwin Headache Research Foundation and Lundbeck. He currently serves on the scientific advisory board of Clusterbusters. He previously served as consultant for PureTech Health, Praxis Precision Medicines, and Beckley Psytech. ABG has no disclosures. EADS currently receives research funding from Wallace Research Foundation and previously received research funding from Heffter Research Institute, Ceruvia Lifesciences, Clusterbusters, and the US Department of Veterans Affairs. She serves on the scientific advisory boards for Ceruvia Lifesciences, Clusterbusters, and OptoSom and previously served as a consultant for PureTech Health. She is named inventor on the following patent related to psychedelics in headache disorders: US20210236523A1.

Document is current